Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001221

Options or other derivatives

  • Chief Business - Strategy Off acquired 1,401,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lin Patrick Chief Business - Strategy Off 2025-07-24 Grant or award · Restricted Stock Units +1,401,650 1,412,082 D
Loading xslF345X05/form4.xml…